
Unleashing Hope: Longboard Pharmaceuticals Begins Groundbreaking Phase 3 DEEp-SEA Trial for Bexicaserin in Dravet Syndrome
Unleashing Hope: Longboard Pharmaceuticals Begins Groundbreaking Phase 3 DEEp-SEA Trial for Bexicaserin in Dravet Syndrome Description: LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has initiated its global Phase 3 DEEp SEA Study evaluating its investigational…